Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance

Metabolism: Clinical and Experimental

Volumn 55, Issue 11, 2006, Pages 1495-1499

  Janowska, Joanna ^a   Zahorska Markiewicz, Barbara ^a   Olszanecka Glinianowicz, Magdalena ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 6; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC PARAMETERS; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESISTIN; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749543444     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.06.020     Document Type: Article

References (44)

1. Basard J.P., Jardel C., Bruckert E., et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 (2000) 3338-3342
2. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
3. Mohamed-Ali V., Goodrik A., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
4. Mohamed-Ali V., Pinkney J.H., and Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes 22 (1998) 1145-1158
5. Basard J.P., Jardel C., Dellatre J., et al. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 (1999) 2221-2222
6. Maachi M., Pironi L., Brukert E., et al. Systemic low-grade inflammation is related to both circulating and adipose tissues TNF-α, leptin and IL-6 levels in obese women. Int J Obes 28 (2004) 993-997
7. Hardardottirn I., Grunfeld C., and Feingold K.R. Effects on endotoxin and cytokines on lipid metabolism. Lipidology 5 (1994) 207-271
8. Zahorska-Markiewicz B., Janowska J., Olszanecka-Glinianowicz M., and Żurakowski A. Serum concentration of TNF α and soluble TNFα receptors in obesity. Int J Obes 24 (2000) 139-195
9. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Janowska J., Kocełak P., Śeliwa M., and Żurakowski A. Serum concentration of tumor necrosis factor TNFα and its soluble receptors in obese women with insulin resistance. Endokrynol Pol 54 (2003) 414-420
10. Hauner H., Bender M., Haastert B., et al. Plasma concentration of soluble TNF-alpha receptors in obese subject. Int J Obes Relat Metab Disord 22 (1998) 1239-1243
11. Winkler G., Kiss S., Keszthelyi L., et al. Expression of tumor necrosis factor (TNF α) protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNFα, soluble serum receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149 (2003) 129-135
12. Steppan C.M., Bailey S.T., Bliat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
13. Rajala M.W., Obici S., Schere P.E., et al. Adipose-derived resistin and gut-derived resistin-like molecule ob selectively impair insulin action on glucose production. J Clin Invest 111 (2003) 225-230
14. Lerkhe M, Reilly MP, Millington SC, et al: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004;1:e45, 161-68.
15. Nagaev I., and Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285 (2001) 561-562
16. Savage D.B., Sewter C.P., Klink E.S., et al. Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferators-activated receptor-gamma action in humans. Diabetes 50 (2001) 2199-2202
17. Olefsky J.M., and Saltiel A.R. PPAR-gamma and the treatment of insulin resistance trends. Endocrinol Metab 11 (2000) 362-368
18. Way J.M., Gorgun C.Z., Tong Q., et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator activated receptor γ agonists. J Biol Chem 23 (2001) 25651-25653 Papers in Press
19. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus (1999), Department of Noncommunicable Disease Surveillance, WHO, Geneva
20. Banerjee R.R., Rangwala S.M., Shapiro S.M., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
21. Shamina R., Rangwala A., Rich S., et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53 (2004) 1937-1941
22. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B., et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88 (2003) 5452-5455
23. Fujinami A., Obayashi H., Ohta K., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339 (2004) 57-63
24. Chen C.-C., Li T.-C., Li C.-I., et al. Serum resistin level among healthy subject: relationship to anthropometric and metabolic parameters. Metab Clin Exp 54 (2005) 471-475
25. Silha J.V., Krsek M., Skrha J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 (2000) 331-335
26. Heilbronn L.K., Rood J., Janderova L., et al. Relationship between serum resistin concentration and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89 (2004) 1844-1848
27. Utzschneider K.M., Carr D.B., Tong J., et al. Resistin is not associates with insulin or metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
28. Iqbal N., Seshadri P., Stern L., et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 9 (2005) 161-165
29. Janke J., Engeli S., Gorzelniak K., et al. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10 (2002) 1-5
30. Vendredell J., Broch M., Vilarrasa N., et al. Resistin, adiponectin, gherlin, leptin, and proinflammatory cytokines: relationship in obesity. Obes Res 12 (2004) 962-971
31. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
32. Yudkin J.S., Stehouwer C.D.A., et al. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
33. Azuma K., Katsukawa F., Oguchi S., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 10 (2002) 1-5
34. Peraldi P., and Spielman B. TNF-α and insulin resistance: summary and future prospect. Mol Cell Biochem 182 (1998) 169-175
35. Glowinska B., and Urban M. Selected cytokines IL-6, IL-10, MCP-1, TNF-alpha, in children with atherosclerosis risk factors; obesity, hypertension, diabetes. Wiad Lek 56 (2003) 109-116
36. Dandona P., Aljada A., and Bandyopadhyaya A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004) 4-7
37. Bo S., Gambino R., Pagani A., et al. Relationship between human serum resistin, inflammatory markers and insulin resistance. Int J Obes Relat Metab Disord (2005)
38. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
39. Kaser S., Kaser A., Sandhofer A., et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309 (2003) 286-290
40. Stejskal D., Adamovska S., Bartek J., et al. Resistin concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Papers 147 (2003) 63-69
41. Shetty G.K., Economides P.A., Horton E.S., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2245-2450
42. Muredach P., Reilly M.B., Lerkhe M., et al. Resistin is inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
43. Volarowa de Courten B., Degawa-Yamauchi M., Considine R.V., et al. High serum resistin is associated with an increase adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 5 (2004) 1279-1284
44. Jove M., Planavila A., Cabrero A., et al. Reduction in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. Metabolism 52 (2003) 351-355